AGMB — Agomab Therapeutics NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Agomab Therapeutics NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.7	122	171
Net Total Accounts Receivable
Net Total Receivables	3.33	17	2.12
Total Other Current Assets
Total Current Assets	71.1	139	174
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.062	1.61	1.99
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	101	171	206
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.7	10.9	9.13
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	34.7	19.8	18.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	66.2	151	188
Total Liabilities & Shareholders' Equity	101	171	206
Total Common Shares Outstanding